Agilent Technologies (NYSE:A) Hits New 12-Month High – Here’s What Happened

Agilent Technologies, Inc. (NYSE:A) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $160.51 and last traded at $159.55, with a volume of 1371818 shares changing hands. The stock had previously closed at $156.30.

Analyst Ratings Changes

Several analysts have recently commented on A shares. Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective for the company. Robert W. Baird increased their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. TD Cowen upped their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Finally, Barclays increased their price target on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Price Performance

The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The business has a 50-day moving average of $136.98 and a 200 day moving average of $126.00. The firm has a market capitalization of $45.22 billion, a PE ratio of 32.15, a price-to-earnings-growth ratio of 2.75 and a beta of 1.25.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Institutional Trading of Agilent Technologies

Hedge funds have recently bought and sold shares of the business. Greenleaf Trust lifted its stake in shares of Agilent Technologies by 0.8% during the 2nd quarter. Greenleaf Trust now owns 8,117 shares of the medical research company’s stock valued at $1,078,000 after buying an additional 68 shares in the last quarter. Fiduciary Trust Co grew its stake in Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares in the last quarter. Sapient Capital LLC raised its holdings in Agilent Technologies by 4.2% during the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after acquiring an additional 85 shares during the period. Plan A Wealth LLC lifted its position in shares of Agilent Technologies by 3.2% during the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after acquiring an additional 92 shares in the last quarter. Finally, UNIVEST FINANCIAL Corp lifted its position in shares of Agilent Technologies by 1.3% during the second quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock worth $949,000 after acquiring an additional 93 shares in the last quarter. 87.41% of the stock is currently owned by institutional investors.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.